Il rapporto
Notizie verificate su finanziamenti, sedi centrali e leadership delle aziende più innovative al mondo
483 report e oltre
Pixelgen Technologies Raises $15.5M Series B for Cell Mapping Platform
Pixelgen Technologies raised a $15.5 million Series B led by new investor Flat Capital to accelerate global commercialization of its Proxiome Kit.
MEDIPOST Raises $140M | Regenerative Medicine for Osteoarthritis
Regenerative medicine company MEDIPOST secures $140 million for stem cell therapy treating knee osteoarthritis.
10x Genomics raises $55M Series E at $500M valuation
10x Genomics raises $55M in Series E at $500M valuation. Single-cell genomics and spatial biology...
Palantir achieves $45B valuation with $200M IPO funding
Palantir reaches $45B valuation through $200M IPO funding, solidifying its position as a data analytics industry leader.
Sana Biotechnology Raises $300M PIPE
Cell engineering company developing ex vivo and in vivo cell therapies for diabetes, cancer, and genetic diseases
Arsenal Biosciences raises $325M Series C
Arsenal Biosciences raises $325M in Series C. Cell therapy company developing programmable T-cell therapies for solid tumors...
Celgene Ventures Headquarters - Office Location & Address
Discover Celgene Ventures's headquarters at 86 Morris Ave, Summit, NJ 07901. Investment arm of Celgene backing early-stage biotechnology and pharmaceutical companies. Focus on oncology, immunology, inflammation, and cell therapy innovations.
Brooklyn Bridge Ventures Headquarters - Office Location & Address
Discover Brooklyn Bridge Ventures's headquarters at 68 Jay St, Brooklyn, NY 11201. Pre-seed venture capital firm investing in NYC area startups at company formation stage. Single-person fund backing technical and non-technical founders building early-stage products.
10x Genomics Raises $55M in Series E
10x Genomics, a Biotech company based in Pleasanton, CA, has raised $55M in Series E at a $500M valuation led by Softbank Vision Fund, Fidelity.
Visualizzazione di 9 report • Pagina 1 • Categoria: all
Rimani avanti rispetto al mercato
Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.